Vietnam Cardiovascular Devices Market Overview, 2031

Key Insights

• Interventional electrophysiology and structural heart therapies are undergoing a major shift toward minimally invasive, low-trauma modalities. High-profile technological breakthroughs include the clinical expansion of Pulsed-Field Ablation (PFA) systems such as Medtronic’s PulseSelect and Boston Scientific’s Farapulse which utilize tissue-selective electroporation to isolate pulmonary veins with significantly lower risks of collateral esophageal or phrenic nerve trauma. Concurrently, the approval and deployment of dual-chamber leadless pacemakers (e.g., Abbott's AVEIR DR) and transcatheter mitral valve replacement systems (such as Edwards Lifesciences' SAPIEN M3) are expanding treatment access for elderly and inoperable cardiac patient cohorts.
• Diagnostic and monitoring hardware is increasingly paired with Software as a Medical Device (SaMD) and machine learning algorithms. Advanced AI models integrated into continuous wearable patch ECGs, smart implantable loop recorders (ILRs), and remote patient monitoring platforms can detect subtle electrocardiographic changes long before symptomatic onset. As CAD (Coronary Artery Disease) and severely calcified peripheral lesions become more prevalent, interventional devices aimed at modifying vessel compliance without high-pressure balloon trauma are seeing record adoption.

Market Outlook

• Driven by public and private healthcare payers seeking to curb high inpatient bed costs and shorten recovery timelines, ASCs represent the fastest-growing end-user care delivery segment. Consequently, medical device vendors are reorienting product designs toward compact, mobile diagnostic Cath Lab imaging equipment, single-use electrophysiology catheters, and integrated cloud-telemetry software to meet outpatient facility requirements.
• International medical device manufacturers face an increasingly complex commercial landscape characterized by stringent pre-market regulatory audits, value-based hospital procurement, and state-enforced price controls. Government-led bulk purchasing initiatives such as Volume-Based Procurement (VBP) in China, National Health Insurance (NHI) price recalculations in Japan and South Korea, and centralized public tenders across Latin America and the Middle East continue to compress profit margins on mature, commoditized product categories like standard drug-eluting stents (DES) and diagnostic catheters.

Market Dynamics

Driver: Aging demographics, and rapid transition to minimally invasive interventions
The overarching catalyst propelling the global cardiovascular devices market is the relentless epidemiological rise of cardiovascular diseases (CVD) which remain the leading cause of mortality worldwide, accounting for over 18.6 million deaths annually driven by an rapidly aging global population and rising rates of lifestyle-related comorbidities like type 2 diabetes, hypertension, and severe arterial calcification. To accommodate frail, high-risk, or elderly patient cohorts who cannot tolerate the physiological stress of traditional open-heart surgery, the global cardiology landscape is undergoing a structural paradigm shift toward minimally invasive percutaneous procedures.
Challenge: Complex multi-jurisdictional regulatory audits and supply chain vulnerabilities
A major commercial and operational headwind facing medical technology developers globally is navigating systemic pricing compression enforced by centralized healthcare cost-containment policies alongside increasingly stringent regulatory clearance mandates. Regulatory authorities such as the US FDA, the EU under Medical Device Regulation (MDR) frameworks, China’s NMPA, Japan’s PMDA, and Brazil’s ANVISA have significantly raised the compliance bar for high-risk Class III and Class IV active cardiovascular implants.
Trend: SaMD analytics and non-thermal ablation, and outpatient care migration
A dominant structural trend reshaping the global cardiovascular landscape is the integration of digital health, artificial intelligence (AI), and low-trauma interventional modalities, coupled with the rapid migration of procedures toward outpatient care settings. Diagnostic and monitoring hardware is increasingly paired with Software as a Medical Device (SaMD) and cloud-connected remote telemetry platforms.

Segment Analysis

Cardiovascular Devices By Device Type
• Therapeutic and surgical cardiovascular devices are increasingly evolving from standalone intervention tools into integrated treatment platforms that combine mechanical therapy, sensing, imaging, navigation, and software. The segment includes cardiac rhythm-management systems, catheters, stents, heart valves, grafts, ventricular-assist technologies, and other implantable or interventional products. A key differentiator is the shift toward minimally invasive and tissue-sparing approaches, including leadless pacing, catheter-based valve replacement or repair, advanced ablation, and image-guided intervention.
• Diagnostic and monitoring devices are moving beyond episodic testing toward continuous, connected cardiovascular surveillance. ECG systems, remote cardiac monitors, wearable sensors, implantable loop recorders, imaging platforms, and physiological-monitoring technologies increasingly generate longitudinal information rather than a single diagnostic snapshot. AI-assisted interpretation can help identify rhythm abnormalities and other clinically relevant patterns, while cloud connectivity enables information to reach clinicians outside conventional hospital environments.



Cardiovascular Devices By Application
• The CAD segment is characterized by a continued transition from conventional angioplasty toward precision-guided and increasingly individualized coronary intervention. Stents and balloon catheters are being complemented by intravascular imaging, physiological assessment, specialized guidewires, atherectomy, and other lesion-preparation technologies that allow physicians to characterize anatomy and optimize treatment during the procedure. Drug-delivery technologies remain important, while device development increasingly focuses on deliverability, vessel compatibility, reduced procedural trauma, and improved long-term outcomes.
• The heart-failure segment is increasingly centered on long-term disease management rather than isolated acute intervention. Cardiac-resynchronization therapy, ICDs, pacemakers, ventricular-assist devices, implantable sensors, and remote-monitoring systems can contribute to different stages of disease management. A notable evolution is the ability of implanted devices to generate physiological information that can be reviewed remotely, supporting earlier identification of changes in a patient’s condition. This makes connectivity, automated alerts, battery longevity, device programmability, and integration with chronic-care workflows important differentiators alongside the therapeutic function itself.
• Cardiac-arrhythmia applications are increasingly defined by the convergence of electrophysiological diagnosis, mapping, ablation, pacing, defibrillation, and continuous rhythm surveillance. Modern systems can combine high-resolution electrical mapping with catheter navigation and increasingly automated analysis, while implantable devices provide both therapy and diagnostic information. Leadless pacemakers, subcutaneous defibrillators, advanced CRT systems, implantable loop recorders, and newer ablation approaches are broadening the range of treatment configurations available for different patient anatomies and clinical needs.
• Structural-heart applications are undergoing a major technological shift toward catheter-based replacement and repair, particularly for patients who may benefit from less invasive alternatives to conventional open-heart surgery. The segment encompasses transcatheter valve-replacement systems, surgical and biological valves, valve-repair technologies, occluders, delivery systems, and advanced cardiac imaging. Imaging is particularly important because structural-heart procedures depend on detailed anatomical assessment, device positioning, procedural guidance, and post-intervention evaluation.
• Other applications encompass peripheral vascular intervention, congenital cardiovascular procedures, mechanical circulatory support, vascular grafting, emergency cardiac technologies, intensive-care monitoring, and emerging digital cardiovascular solutions. This category is becoming increasingly diverse because cardiovascular technology now spans physical implants, minimally invasive instruments, software, sensors, imaging, and connected monitoring systems. Mechanical circulatory-support technologies can provide temporary or longer-term assistance, while digital systems increasingly support rehabilitation, surveillance, clinical decision-making, and longitudinal disease management.

Cardiovascular Devices By End-User
• Hospitals and cardiac centers remain the central environment for complex cardiovascular diagnosis, intervention, surgery, electrophysiology, structural-heart procedures, and intensive monitoring because they can combine catheterization laboratories, hybrid operating rooms, advanced imaging, cardiac intensive-care facilities, and multidisciplinary specialist teams. They also provide the infrastructure needed for complications and emergency escalation during high-risk procedures. Beyond treatment, hospitals increasingly function as technology hubs where implantable devices, remote-monitoring platforms, AI-enabled diagnostics, and digital clinical systems are integrated into broader cardiovascular pathways.
• ASCs are becoming increasingly relevant as cardiovascular technology enables less invasive procedures with shorter recovery requirements. Catheter-based interventions, selected electrophysiology procedures, vascular interventions, and other appropriately screened treatments can potentially be incorporated into day-care or short-stay pathways when adequate emergency support and post-procedure monitoring are available. This favors devices with simplified delivery systems, predictable procedural workflows, reduced tissue trauma, and rapid recovery characteristics. The expansion of ambulatory care therefore depends not only on clinical suitability but also on the ability of devices and facilities to maintain safety outside traditional inpatient environments.
• Specialty clinics are becoming important nodes for cardiac diagnostics, rhythm management, heart-failure follow-up, preventive cardiology, rehabilitation, and device surveillance. Compact ECG systems, Holter monitors, wearable technologies, portable imaging, and software-based diagnostic tools allow more cardiovascular assessment to occur outside major hospitals. These clinics can also serve as an intermediate layer between tertiary intervention and home care, particularly when remote monitoring platforms allow specialists to review patient-generated information without requiring every encounter to be conducted in person.
• Home-care cardiovascular devices are increasingly focused on remote monitoring, wearable sensing, connected implantable devices, and digitally supported chronic-care management. Wearable ECG systems, remote cardiac monitors, connected blood-pressure and physiological sensors, and implantable-device monitoring can extend observation beyond the clinical facility and support earlier communication with healthcare professionals. The most distinctive shift is toward continuous or repeated data collection combined with automated analysis and clinician oversight rather than isolated home measurements.


Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031

Aspects covered in this report
• Cardiovascular Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Device Type
• Therapeutic and Surgical Devices
• Diagnostic and Monitoring Devices

By Application
• Coronary Artery Disease (CAD)
• Heart Failure
• Cardiac Arrhythmia
• Structural Heart Disease
• Other Applications

By End User
• Hospitals & Cardiac Centers
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Home-Care Settings